Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,348 | 8,431 | 566 | 64 | 51 |
| Receivables | 339 | N/A | N/A | N/A | N/A |
| TOTAL | $7,774 | $8,546 | $688 | $158 | $155 |
| Non-Current Assets | |||||
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,310 |
| TOTAL | $2,300 | $2,300 | $2,300 | $2,300 | $2,310 |
| Total Assets | $10,073 | $10,846 | $2,987 | $2,457 | $2,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35 | 13 | 67 | 64 | 271 |
| Accrued Expenses | 58 | 50 | 481 | 912 | 560 |
| Other current liabilities | N/A | N/A | 22 | N/A | N/A |
| TOTAL | $93 | $63 | $2,338 | $1,248 | $982 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 53 | 132 | 11 | 25 | 21 |
| TOTAL | $53 | $132 | $11 | $25 | $21 |
| Total Liabilities | $146 | $195 | $2,349 | $1,272 | $1,004 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,537 | 61,374 | 32,494 | 28,511 | 21,264 |
| Common Shares | 7 | 5 | 3 | 3 | 2 |
| Retained earnings | -19,786 | -16,890 | -12,797 | -10,563 | -8,496 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 304 |
| TOTAL | $9,927 | $10,651 | $639 | $1,185 | $1,461 |
| Total Liabilities And Equity | $10,073 | $10,846 | $2,987 | $2,457 | $2,464 |